HGC Investment Management Inc. - BIOPLUS ACQUISITION CORP ownership

BIOPLUS ACQUISITION CORP's ticker is and the CUSIP is G11217109. A total of 12 filers reported holding BIOPLUS ACQUISITION CORP in Q4 2022. The put-call ratio across all filers is - and the average weighting 0.1%.

Quarter-by-quarter ownership
HGC Investment Management Inc. ownership history of BIOPLUS ACQUISITION CORP
ValueSharesWeighting
Q1 2023$10,480
+3.4%
1,000,0000.0%1.08%
+142.7%
Q4 2022$10,140
-99.8%
1,000,000
+100.0%
0.44%
+30.7%
Q3 2022$5,020,000
-49.9%
500,000
-50.0%
0.34%
+10.4%
Q2 2022$10,020,000
+100.8%
1,000,000
+100.0%
0.31%
+3.0%
Q1 2022$4,990,000
-0.2%
500,0000.0%0.30%
-3.6%
Q4 2021$5,000,000500,0000.31%
Other shareholders
BIOPLUS ACQUISITION CORP shareholders Q4 2022
NameSharesValueWeighting ↓
FIFTH LANE CAPITAL, LP 30,000$1,030,0000.65%
Wealthspring Capital LLC 243,391$2,423,0000.46%
Spartan Fund Management Inc. 150,000$1,484,0000.31%
HGC Investment Management Inc. 1,000,000$10,020,0000.31%
Atalaya Capital Management LP 250,000$2,518,0000.30%
Schechter Investment Advisors, LLC 110,221$1,090,0000.11%
Bracebridge Capital, LLC 50,000$503,0000.08%
Sage Mountain Advisors LLC 25,610$253,0000.04%
Calamos Advisors LLC 1,000,000$10,070,0000.04%
LMR Partners LLP 250,000$2,515,0000.04%
View complete list of BIOPLUS ACQUISITION CORP shareholders